STOCK TITAN

[Form 4] H.B. Fuller Company Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

H.B. Fuller insider filing: Ms. Heather Campe, Senior Vice President, International Growth, reported transactions dated 08/15/2025. The filing shows a disposition of 22,316.23 shares of common stock in the non-derivative table. On the same date she acquired 36.77 phantom units that convert 1-for-1 into common stock under the company deferred compensation plan and acquired 36.77 underlying shares at an indicated price of $58.97. The report also lists multiple outstanding employee stock options (with strike prices $51.89, $53.57, $64.28, $68.17, $72.94, $77.72) and restricted stock units vesting over 2026–2028, with specific share amounts disclosed for each grant. The form is signed by an attorney-in-fact on 08/18/2025.

Segnalazione insider di H.B. Fuller: la Sig.ra Heather Campe, Senior Vice President, International Growth, ha riportato operazioni in data 08/15/2025. Il documento indica una disposizione di 22.316,23 azioni ordinarie nella tabella non-derivata. Nella stessa data ha acquisito 36,77 unità fantasma convertibili 1:1 in azioni ordinarie secondo il piano di compensazione differita della società e ha acquisito 36,77 azioni sottostanti a un prezzo indicato di $58.97. Il rapporto elenca inoltre diverse opzioni azionarie per dipendenti in corso (con prezzi di esercizio $51.89, $53.57, $64.28, $68.17, $72.94, $77.72) e unità azionarie vincolate che maturano nel periodo 2026–2028, con le quantità specifiche per ciascuna concessione. Il modulo è firmato da un mandatario il 08/18/2025.

Presentación de insider de H.B. Fuller: la Sra. Heather Campe, Senior Vice President, International Growth, informó transacciones con fecha 08/15/2025. El documento muestra una disposición de 22.316,23 acciones ordinarias en la tabla no derivada. En la misma fecha adquirió 36,77 unidades fantasma que se convierten 1 a 1 en acciones ordinarias según el plan de compensación diferida de la compañía y adquirió 36,77 acciones subyacentes a un precio indicado de $58.97. El informe también lista múltiples opciones sobre acciones de empleados pendientes (con precios de ejercicio $51.89, $53.57, $64.28, $68.17, $72.94, $77.72) y unidades de acciones restringidas que vencen entre 2026 y 2028, con montos específicos divulgados para cada concesión. El formulario está firmado por un apoderado el 08/18/2025.

H.B. Fuller 내부자 신고: Heather Campe 부사장(Senior Vice President, International Growth)이 2025-08-15자로 거래를 신고했습니다. 제출서류는 비파생 항목 표에 22,316.23주 보통주 처분을 기재하고 있습니다. 같은 날짜에 회사의 이연보상 계획에 따라 1대1로 보통주로 전환되는 36.77개의 팬텀 단위를 취득했으며, 표기된 가격 $58.97로 36.77기초주식을 취득했습니다. 보고서에는 또한 복수의 미행사 직원 스톡옵션(행사가 $51.89, $53.57, $64.28, $68.17, $72.94, $77.72)과 2026–2028년에 걸쳐 베스팅되는 제한주식단위가 기재되어 있으며, 각 부여별 구체적 주식수도 공개되어 있습니다. 양식은 2025-08-18에 대리인 서명으로 제출되었습니다.

Déclaration d'initié de H.B. Fuller : Mme Heather Campe, Senior Vice President, International Growth, a déclaré des transactions datées du 15/08/2025. Le dépôt indique une cession de 22 316,23 actions ordinaires dans le tableau non dérivé. À la même date, elle a acquis 36,77 unités fantômes convertibles 1 pour 1 en actions ordinaires dans le cadre du plan de rémunération différée de la société et a acquis 36,77 actions sous-jacentes à un prix indiqué de 58,97 $. Le rapport énumère également plusieurs options d'achat d'actions employé en cours (prix d'exercice : 51,89 $, 53,57 $, 64,28 $, 68,17 $, 72,94 $, 77,72 $) et des unités d'actions restreintes venant à échéance entre 2026 et 2028, avec les montants spécifiques pour chaque attribution. Le formulaire est signé par un mandataire le 18/08/2025.

Insider-Meldung von H.B. Fuller: Frau Heather Campe, Senior Vice President, International Growth, meldete Transaktionen vom 15.08.2025. Die Meldung weist in der Nicht-Derivate-Tabelle eine Veräußerung von 22.316,23 Stammaktien aus. Am selben Datum erwarb sie 36,77 Phantom-Einheiten, die 1:1 in Stammaktien gemäß dem aufgeschobenen Vergütungsplan des Unternehmens umwandelbar sind, und erwarb 36,77 zugrunde liegende Aktien zu einem angegebenen Preis von $58,97. Der Bericht listet zudem mehrere ausstehende Mitarbeiteraktienoptionen (Ausübungspreise $51.89, $53.57, $64.28, $68.17, $72.94, $77.72) sowie Restricted Stock Units, die in den Jahren 2026–2028 vesten, mit den jeweils offengelegten Stückzahlen. Das Formular ist am 18.08.2025 von einem Bevollmächtigten unterzeichnet.

Positive
  • Receipt of deferred compensation units: acquisition of 36.77 phantom units that convert 1-for-1 into common stock under the Key Employee Deferred Compensation Plan.
  • Clear disclosure of equity awards: multiple employee stock options and restricted stock units disclosed with strike prices, exercisable/expiration dates and vesting schedules, supporting transparency on insider compensation.
Negative
  • Share disposition: a sale/disposition of 22,316.23 shares of common stock was reported on 08/15/2025.
  • Potential future dilution: numerous outstanding options and RSUs (detailed strike prices and share amounts) could convert to common stock over time.

Insights

TL;DR: Insider sold 22,316.23 shares and received deferred-compensation units and ongoing equity awards, indicating routine compensation-related activity.

The disposition of 22,316.23 shares is explicitly reported and may reflect personal liquidity or portfolio management; the filing does not state the reason for the sale. The acquisition of 36.77 phantom units that convert 1-for-1 to common stock and the reported underlying shares at $58.97 are typical of deferred compensation and dividend-equivalent mechanics. The filing discloses multiple vested and unvested employee stock options with varied strike prices and RSUs that vest in installments through 2028, which demonstrates a standard mix of long-term incentive awards. No material corporate governance events, departures, or extraordinary transactions are disclosed in the form.

TL;DR: Report shows expected equity compensation schedule and one sizeable share disposition; holdings detail strike prices and vesting schedules.

The derivative schedule outlines six employee stock options with explicit strike prices and exercisable/expiration dates, including fully vested options and others vesting 33%/33%/34% over stated schedules. Restricted stock units and phantom units include dividend-equivalent features and 1-for-1 conversion language; specific share counts are provided for each grant. These disclosures allow investors to map potential future dilution from option exercises and RSU conversions, but the form contains no data on total outstanding shares or percentage ownership to quantify dilution here.

Segnalazione insider di H.B. Fuller: la Sig.ra Heather Campe, Senior Vice President, International Growth, ha riportato operazioni in data 08/15/2025. Il documento indica una disposizione di 22.316,23 azioni ordinarie nella tabella non-derivata. Nella stessa data ha acquisito 36,77 unità fantasma convertibili 1:1 in azioni ordinarie secondo il piano di compensazione differita della società e ha acquisito 36,77 azioni sottostanti a un prezzo indicato di $58.97. Il rapporto elenca inoltre diverse opzioni azionarie per dipendenti in corso (con prezzi di esercizio $51.89, $53.57, $64.28, $68.17, $72.94, $77.72) e unità azionarie vincolate che maturano nel periodo 2026–2028, con le quantità specifiche per ciascuna concessione. Il modulo è firmato da un mandatario il 08/18/2025.

Presentación de insider de H.B. Fuller: la Sra. Heather Campe, Senior Vice President, International Growth, informó transacciones con fecha 08/15/2025. El documento muestra una disposición de 22.316,23 acciones ordinarias en la tabla no derivada. En la misma fecha adquirió 36,77 unidades fantasma que se convierten 1 a 1 en acciones ordinarias según el plan de compensación diferida de la compañía y adquirió 36,77 acciones subyacentes a un precio indicado de $58.97. El informe también lista múltiples opciones sobre acciones de empleados pendientes (con precios de ejercicio $51.89, $53.57, $64.28, $68.17, $72.94, $77.72) y unidades de acciones restringidas que vencen entre 2026 y 2028, con montos específicos divulgados para cada concesión. El formulario está firmado por un apoderado el 08/18/2025.

H.B. Fuller 내부자 신고: Heather Campe 부사장(Senior Vice President, International Growth)이 2025-08-15자로 거래를 신고했습니다. 제출서류는 비파생 항목 표에 22,316.23주 보통주 처분을 기재하고 있습니다. 같은 날짜에 회사의 이연보상 계획에 따라 1대1로 보통주로 전환되는 36.77개의 팬텀 단위를 취득했으며, 표기된 가격 $58.97로 36.77기초주식을 취득했습니다. 보고서에는 또한 복수의 미행사 직원 스톡옵션(행사가 $51.89, $53.57, $64.28, $68.17, $72.94, $77.72)과 2026–2028년에 걸쳐 베스팅되는 제한주식단위가 기재되어 있으며, 각 부여별 구체적 주식수도 공개되어 있습니다. 양식은 2025-08-18에 대리인 서명으로 제출되었습니다.

Déclaration d'initié de H.B. Fuller : Mme Heather Campe, Senior Vice President, International Growth, a déclaré des transactions datées du 15/08/2025. Le dépôt indique une cession de 22 316,23 actions ordinaires dans le tableau non dérivé. À la même date, elle a acquis 36,77 unités fantômes convertibles 1 pour 1 en actions ordinaires dans le cadre du plan de rémunération différée de la société et a acquis 36,77 actions sous-jacentes à un prix indiqué de 58,97 $. Le rapport énumère également plusieurs options d'achat d'actions employé en cours (prix d'exercice : 51,89 $, 53,57 $, 64,28 $, 68,17 $, 72,94 $, 77,72 $) et des unités d'actions restreintes venant à échéance entre 2026 et 2028, avec les montants spécifiques pour chaque attribution. Le formulaire est signé par un mandataire le 18/08/2025.

Insider-Meldung von H.B. Fuller: Frau Heather Campe, Senior Vice President, International Growth, meldete Transaktionen vom 15.08.2025. Die Meldung weist in der Nicht-Derivate-Tabelle eine Veräußerung von 22.316,23 Stammaktien aus. Am selben Datum erwarb sie 36,77 Phantom-Einheiten, die 1:1 in Stammaktien gemäß dem aufgeschobenen Vergütungsplan des Unternehmens umwandelbar sind, und erwarb 36,77 zugrunde liegende Aktien zu einem angegebenen Preis von $58,97. Der Bericht listet zudem mehrere ausstehende Mitarbeiteraktienoptionen (Ausübungspreise $51.89, $53.57, $64.28, $68.17, $72.94, $77.72) sowie Restricted Stock Units, die in den Jahren 2026–2028 vesten, mit den jeweils offengelegten Stückzahlen. Das Formular ist am 18.08.2025 von einem Bevollmächtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Campe Heather

(Last) (First) (Middle)
1200 WILLOW LAKE BOULEVARD
P.O. BOX 64683

(Street)
ST. PAUL MN 55164-0683

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
FULLER H B CO [ FUL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Sr. VP, International Growth
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 22,316.23(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Units $0.0000(2) 08/15/2025 A 36.77 (3) (3) Common Stock 36.77 $58.97 4,856.65(4) D
Employee Stock Option (Right-to-Buy) $51.89 01/27/2022(5) 01/27/2031 Common Stock 19,520 19,520 D
Employee Stock Option (Right-to-Buy) $53.57 01/25/2019(5) 01/25/2028 Common Stock 21,834 21,834 D
Employee Stock Option (Right-to-Buy) $64.28 01/27/2026(6) 01/27/2035 Common Stock 10,831 10,831 D
Employee Stock Option (Right-to-Buy) $68.17 01/24/2024(6) 01/24/2033 Common Stock 10,730 10,730 D
Employee Stock Option (Right-to-Buy) $72.94 01/24/2023(5) 01/24/2032 Common Stock 11,636 11,636 D
Employee Stock Option (Right-to-Buy) $77.72 01/26/2025(6) 01/26/2034 Common Stock 9,928 9,928 D
Restricted Stock Units $0.0000(7) 01/24/2024(8) 01/24/2026 Common Stock 621.44 621.44(9) D
Restricted Stock Units $0.0000(7) 01/26/2025(8) 01/26/2027 Common Stock 1,134.66 1,134.66(9) D
Restricted Stock Units $0.0000(7) 01/27/2026(8) 01/27/2028 Common Stock 1,910.94 1,910.94(9) D
Explanation of Responses:
1. Amount includes shares acquired pursuant to a dividend reinvestment plan.
2. These units (acquired after 12-31-04) convert into shares of common stock on a 1-for-1 basis.
3. These units (acquired after 12-31-04) convert into shares of common stock upon the earlier of certain termination events as specified in the Key Employee Deferred Compensation Plan or such earlier date as selected by the participant, subject to holding periods required by law.
4. Amount includes stock units acquired pursuant to a dividend equivalent feature.
5. This option is 100% vested.
6. This option vests in three annual installments (33%, 33%, and 34%) beginning on the date shown.
7. These restricted stock units convert into shares of common stock on a 1-for-1 basis.
8. These restricted stock units vest in three annual installments (33%, 33%, and 34%) beginning on the date shown.
9. Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.
/s/ Patrick J. Seul, Attorney-in-Fact 08/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Heather Campe report on Form 4 for FUL?

The filing reports a disposition of 22,316.23 shares of common stock on 08/15/2025 and the acquisition of 36.77 phantom units (convertible 1-for-1 into common stock) on the same date.

What equity awards does the Form 4 disclose for Heather Campe (FUL)?

The form lists multiple employee stock options with strikes of $51.89, $53.57, $64.28, $68.17, $72.94, and $77.72, plus restricted stock units and phantom units with specified share amounts and vesting schedules.

When do the restricted stock units and options vest or expire?

The filing shows RSUs that vest in three annual installments beginning on grant dates (vesting through 2026–2028) and options with exercisable/expiration dates including expirations in 2028, 2031, 2032, 2033, 2034, and 2035 as listed.

Does the Form 4 explain why the 22,316.23 shares were sold?

No. The filing records the disposition amount and date but does not state the reason for the sale.

Who signed the Form 4 and when was it filed?

The form is signed by /s/ Patrick J. Seul, Attorney-in-Fact with a signature date of 08/18/2025 and transactions dated 08/15/2025.
Fuller H B Co

NYSE:FUL

FUL Rankings

FUL Latest News

FUL Latest SEC Filings

FUL Stock Data

3.18B
53.77M
0.28%
98.7%
2.66%
Specialty Chemicals
Adhesives & Sealants
Link
United States
ST PAUL